Novartis AG's ( VTX:NOVN ) earnings announcement last week was disappointing for investors, despite the decent ...

In May 2024, Google DeepMind released AlphaFold 3, a game changing protein folding model that predicts with 50% better ...

GET MORE AI-GENERATED SIGNALS: November 09, 2024, 00:34 am ET, BY Christie- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

In April 2021, Novartis AG announced a collaboration with Artios Pharma. This collaboration was made to improve both companies’ discovery platforms, leverage their knowledge, and improve the potential ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For the most current information about the device indications for the therapeutic products in this group, go to: ...

EQS-News: APONTIS PHARMA AG / Key word (s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted ...